Long-term Outcomes and Emerging Combinations With Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: A GameOn! Challenge

Long-term Outcomes and Emerging Combinations With Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: A GameOn! Challenge

Treatment of advanced non-small cell lung cancer (NSCLC) has rapidly evolv…

Expiration Date: 9/29/2023

Max Credits: 0.5

View Activity

Advances in B7-H3 as a Therapeutic Target in Advanced Solid Tumors: Rapid Response From Paris

Advances in B7-H3 as a Therapeutic Target in Advanced Solid Tumors: Rapid Response From Paris

Immuno-oncology (IO) continues to evolve as investigators seek therapeutic…

Expiration Date: 9/29/2023

Max Credits: 0.75

View Activity

Challenging Cases in BRAF-Mutated Melanoma: Applying the Latest Advances to Optimize Care

Challenging Cases in BRAF-Mutated Melanoma: Applying the Latest Advances to Optimize Care

Advances in BRAF-targeted agents and their integration into treatment algo…

Expiration Date: 12/21/2022

Max Credits: 1

View Activity

Keeping an Eye Out: Emerging Trends in the Management of Metastatic Uveal Melanoma

Keeping an Eye Out: Emerging Trends in the Management of Metastatic Uveal Melanoma

Uveal melanoma is the most common ocular cancer, typically affecting older…

Expiration Date: 12/21/2022

Max Credits: 0.75

View Activity

Rapid-Fire Roundtable on Melanoma: Focus on Advances in Adjuvant Treatment, Neoadjuvant Treatment, and Management of Metastatic Disease

Rapid-Fire Roundtable on Melanoma: Focus on Advances in Adjuvant Treatment, Neoadjuvant Treatment, and Management of Metastatic Disease

Treatment for patients with advanced melanoma has been revolutionized thro…

Expiration Date: 12/21/2022

Max Credits: 0.75

View Activity

Real-World Insights From Individuals With Lung Cancer in the Context of a Digital Health Coaching Program

Real-World Insights From Individuals With Lung Cancer in the Context of a Digital Health Coaching Program

Lung cancer continues to be the major cause of cancer-related deaths world…

Expiration Date: 12/21/2021

Max Credits: 0

View Activity

Expert Connect: Insights Into the Management of Treatment-Experienced Patients With SCLC

Expert Connect: Insights Into the Management of Treatment-Experienced Patients With SCLC

Small-cell lung cancer (SCLC) accounts for approximately 15% of lung cance…

Expiration Date: 12/20/2021

Max Credits: 0

View Activity

Optimizing Outcomes For Patients With Lung Cancer: Checkpoint Inhibitor Therapy in SCLC and Improving Health Literacy

Optimizing Outcomes For Patients With Lung Cancer: Checkpoint Inhibitor Therapy in SCLC and Improving Health Literacy

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 10/6/2021

Max Credits: 0

View Activity

Optimizing Outcomes For Patients With Lung Cancer: Checkpoint Inhibitor Therapy in NSCLC, Patient Coaching, and Evaluation of Patient Reported Outcomes

Optimizing Outcomes For Patients With Lung Cancer: Checkpoint Inhibitor Therapy in NSCLC, Patient Coaching, and Evaluation of Patient Reported Outcomes

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 8/16/2021

Max Credits: 0

View Activity

Checkpoint Inhibitors as First-line Treatments for Lung Cancer: What You Need to Know

Checkpoint Inhibitors as First-line Treatments for Lung Cancer: What You Need to Know

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 6/29/2021

Max Credits: 0

View Activity